Scientific Program

  • March 14 (Thursday)
  • March 15 (Friday)
  • March 16 (Saturday)

March 14 (Thursday)

[JS01] KAI-KSH Joint Symposium: Immunotherapeutics in Blood Disease

Date & Time March 14 (Thursday) 09:00-10:30 Room Vista I

Immune Checkpoint Inhibitor in Cancer

Seung-Woo Lee (POSTEC, Korea)


Chan Hyuk Kim (KAIST, Korea)

Cytotoxic T Lymphocyte Therapy

Hyewon Lee (National Cancer Center, Korea)

Immune Checkpoint Inhibitor in Lymphoma

Dok Hyun Yoon (Asan Medical Center, Korea)

[SS01] Scientific Session 1: Bone Marrow Failure

Date & Time March 14 (Thursday) 09:00-10:30 Room Vista II


Nack-Gyun Chung (The Catholic University of Korea, Korea)

Germ Line Mutations in Inherited BM Failure

Jean Soulier (Saint-Louis Hospital, France)

Telomere Length and Somatic Mutations in Aplastic Anaemia

Dong Soon Lee (Seoul National University, Korea)

[PL01] Plenary Lecture 1: Gene Therapy in Hematology

Date & Time March 14 (Thursday) 10:45-11:45 Room Vista I+II+III

Application of CRISPR/Cas-9 in Blood Disease

Matthew H. Porteus (Stanford University, USA)

Gene Therapy for Hemophilia

Katherine High (Spark Therapeutics Inc., USA)

[PS] Presidential Symposium

Date & Time March 14 (Thursday) 11:45-12:45 Room Vista I+II+III

Stem Cells in Human AML

Ravindra Majeti (Stanford University, USA)

Optimal treatment of adolescents and young adult ALL

Ching-Hon Pui (St. Jude Children's Research Hospital, USA)

[JS02] KOGO-KSH Joint Session : Genomics for Precision Hematology

Date & Time March 14 (Thursday) 14:55-16:25 Room Vista I

Understanding angioimmunoblastic T-cell lymphoma: From genomics to animal pathology

Jaesang Kim (Ewha Womans University College of Natural Science, Korea)

Genomic Pathogenesis of Epstein–Barr virus (EBV)-induced diffuse Large B Cell Lymphoma

Sung-Yup Cho (Seoul National University College of Medicine, Korea)

Current Status of Precision Hematology

Young-Uk Cho (University of Ulsan College of Medicine, Korea)

Clinical Application of Precision Hematology

Joon-Ho Moon (Kyungpook national university hospital, Korea)

[SS02] Scientific Session 2: How is Multiple Myeloma Developed and Progressed? From 3 Different Viewpoint

Date & Time March 14 (Thursday) 14:55-16:25 Room Vista II

High Risk MM Identifyed by Genomic Analysis

Gareth Morgan (Center for myeloma Research, Institute of Cancer Research, UK)

What Role does Bone Marrow Microenvironment Play on MM Cells

Yusuke Furukawa (Center for Molecular Medicine, Jichi Medical University, Japan)

Antigen-mediated Regulation in MM

Madhav Dhodapkar (Yale University, USA)

[SS03] Scientific Session 3: Transplantation/Cell Therapy

Date & Time March 14 (Thursday) 14:55-16:25 Room Vista III

TK cell therapy

Chiara Bonini (Vita-Salute San Raffaele University, Italy)

Updates on CAR T Cell Therapy for Multiple Myeloma

Jesús Berdeja (Sarah Cannon Research Institute, USA)

New insights into cancer vaccine strategies

Larry Kwak (City of Hope Comprehensive Cancer Center, USA)

[ES01] Educational Session : Iron Metabolism

Date & Time March 14 (Thursday) 14:55-16:25 Room Grand Hall

Iron metabolism in Hemoglobinopathies

Vip Viprakasit (Medicine Siriraj Hospital, Thailand)

Deferasirox for iron overload patients: preserving organ functions

Norbert Gattermann (Heinrich-Heinne University, Dusseldorf, Germany)

Managing side effects in iron chelation therapy

Heather Leitch (University of British Columbia, Canada)

[SS04] Scientific Session 4 : Myeloproliferative Neoplasm

Date & Time March 14 (Thursday) 16:40-18:10 Room Vista I

Clinical significance of genetic stratification of MPN patients

Robert Kralovics (Medical University of Vienna, Austria)

Molecular mechanism of MPN development by mutant calreticulin

Norio Komatsu (Juntendo University School of Medicine, Japan)

Interferon treatment for MPN

Jean-Jacques Kiladjian (Clinical Pharmacology, Paris 7 University, France)

[SS05] Scientific Session 5 : Bleeding Disorder/Thrombosis

Date & Time March 14 (Thursday) 16:40-18:10 Room Vista II

Gene therapy for hemophilia

Glenn F. Pierce (World Federation of Hemophilia, USA)

Individualized treatment for hemophilia : population pharmacokinetics approach

Cindy Yeung (McMaster University, Canada)

Mechanisms of cancer-associated thrombosis

Nigel Mackman (University of North Carolina, USA)

[SS06] Scientific Session 6: Pediatric Disease: Inherited hematologic malignancies

Date & Time March 14 (Thursday) 16:40-18:10 Room Vista III

Inherited Hematologic Malignancies

Lucy Godley (The University of Chicago, USA)

GATA2 leukemogenesis

Jean Donadieu (APHP Trousseau, Registre des Neutropenies, Paris, France)

Roles of Monosomy 7 and SAMD9/SAMD9L mutations in myeloid leukemogenesis

Hirotaka Matsui (Kumamoto University, Japan)

[ES02] Educational Session 2 : Indolent Lymphoma: From Genetics to the Clinic

Date & Time March 14 (Thursday) 16:40-18:10 Room Grand Hall

Mantle Cell Lymphoma

Mats Jerkeman (Department of Oncology, Skane University Hospital, SE-221 85 Lund, Sweden)

Follicular Lymphoma

Gilles Salles (Hospices Civils de Lyon-Universit´e de Lyon, Pierre-B´enitecedex, Lyon, France)

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Wei Xu (First Affiliated Hospital of Nanjing Medical University, China)